Pioglitazone has also been shown to reduce the production of a wide range of proinflammatory molecules, including iNOS (55), providing further evidence for the importance of NO production by monocyte-derived cells in the pathogenesis of influenza infection. This evidence concerns the gene NOS2 and influenza.